Skip to main content
Tech.euFundingExplorerBeta

Octarine Bio

Synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration

Octarine Bio has raised €13M across 4 funding rounds from 10 investors, most recently a round in Jan 2026. Based in Copenhagen, Denmark; founded 2018; active in Cleantech. Data as of 28 Oct 2026.

Copenhagen, DenmarkFounded 2018octarinebio.com ↗
Total raised
€13M
€12,876,588
Funding rounds
4
Investors
10
distinct backers
Active since
2020-11
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
Octarine Bio — funding by year — interactive chart.
Data table
Octarine Bio — funding by year
2020€1.5M
2022€2.0M
2023€4.3M
2026€5.0M

Signals

High confidence
Raise-next likelihood34
base rate 30% for Other
  • ▲ In typical raise window
  • ▼ Low backer re-investment
Exit likelihood20
base rate 11% (2+ rounds)
  • ▲ 4 rounds raised
  • ▲ 8y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds

Similar companies

same sector or country

Global coverage: FundingData